Breast biopsies, which can conclusively diagnose the presence of a tumor, suffer from a number of procedural limitations. One big issue is that during the excision of every sample, the physician can’t easily confirm whether the taken tissue really does come from the targeted lesion. Hologic‘s Brevera biopsy system has now been approved (Read more...)